Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer-associated amyloid plaques in the brain

Fee cuts come at the same time as seniors receive a Social Security cost-of-living increase for 2023 of up to 9 or 10 percent

Association found for Alzheimer and Parkinson disease cases diagnosed before 60 years of age

Bilateral theta burst stimulation noninferior to standard bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression

Association found for Alzheimer and Parkinson disease cases diagnosed before 60 years of age

Bilateral theta burst stimulation noninferior to standard bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression

Findings for pharmacotherapy, psychotherapy, or combination treatment

Findings for pharmacotherapy, psychotherapy, or combination treatment

Exposure to Hurricane Sandy in utero linked to increased risk for depressive disorders, anxiety disorders, attention-deficit/behavioral disorders